172 related articles for article (PubMed ID: 1646284)
1. Role of viral ribonucleotide reductase in the increase of dTTP pool size in herpes simplex virus-infected Vero cells.
Daikoku T; Yamamoto N; Maeno K; Nishiyama Y
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1441-4. PubMed ID: 1646284
[TBL] [Abstract][Full Text] [Related]
2. The sources of thymidine nucleotides for virus DNA synthesis in herpes simplex virus type 2-infected cells.
Nutter LM; Grill SP; Cheng YC
J Biol Chem; 1985 Oct; 260(24):13272-5. PubMed ID: 2997161
[TBL] [Abstract][Full Text] [Related]
3. Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells.
Marcello A; Pizzato M; Loregian A; Palù G
Biochem Soc Trans; 1995 Nov; 23(4):627S. PubMed ID: 8654812
[No Abstract] [Full Text] [Related]
4. Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?
Nutter LM; Grill SP; Cheng YC
Biochem Pharmacol; 1985 Mar; 34(6):777-80. PubMed ID: 2983736
[TBL] [Abstract][Full Text] [Related]
5. Deoxyribonucleoside triphosphate pools in synchronized human cells infected with herpes simplex virus types 1 and 2.
Roller B; Cohen GH
J Virol; 1976 Apr; 18(1):58-64. PubMed ID: 176471
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV).
Langelier Y; Buttin G
J Gen Virol; 1981 Nov; 57(Pt 1):21-31. PubMed ID: 6172549
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
Petrowsky H; Roberts GD; Kooby DA; Burt BM; Bennett JJ; Delman KA; Stanziale SF; Delohery TM; Tong WP; Federoff HJ; Fong Y
J Virol; 2001 Aug; 75(15):7050-8. PubMed ID: 11435585
[TBL] [Abstract][Full Text] [Related]
8. The herpes simplex virus type 1 temperature-sensitive mutant ts1222 has a single base pair deletion in the small subunit of ribonucleotide reductase.
Preston VG; Darling AJ; McDougall IM
Virology; 1988 Dec; 167(2):458-67. PubMed ID: 2849235
[TBL] [Abstract][Full Text] [Related]
9. Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: infection of the PC 12 cell.
Rubenstein R; Price RW
Arch Virol; 1983; 78(1-2):49-64. PubMed ID: 6316875
[TBL] [Abstract][Full Text] [Related]
10. Restricted replication of herpes simplex virus type 1 in murine embryonal carcinoma cells.
Bell JC; Campione-Piccardo J; Craig J; Reuhl KR; McBurney MW
J Gen Virol; 1987 Feb; 68 ( Pt 2)():555-68. PubMed ID: 3029290
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
De Clercq E; Bernaerts R; Merta A; Rosenwirth B
Mol Pharmacol; 1990 May; 37(5):658-64. PubMed ID: 2160059
[TBL] [Abstract][Full Text] [Related]
12. The herpes simplex virus ribonucleotide reductase is required for ocular virulence.
Brandt CR; Kintner RL; Pumfery AM; Visalli RJ; Grau DR
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2043-9. PubMed ID: 1654368
[TBL] [Abstract][Full Text] [Related]
13. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice.
Yamada Y; Kimura H; Morishima T; Daikoku T; Maeno K; Nishiyama Y
J Infect Dis; 1991 Dec; 164(6):1091-7. PubMed ID: 1659596
[TBL] [Abstract][Full Text] [Related]
14. Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Biochem Cell Biol; 1991; 69(5-6):409-14. PubMed ID: 1654943
[TBL] [Abstract][Full Text] [Related]
15. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
De Clercq E; Bères J; Bentrude WG
Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleoside triphosphate pools in cells infected with deoxypyrimidine kinaseless herpes simplex virus.
Jamieson AT; Bjursell G
J Gen Virol; 1976 Apr; 31(1):115-23. PubMed ID: 177723
[TBL] [Abstract][Full Text] [Related]
17. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.
Aduma PJ; Gupta SV; De Clercq E
Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleotide reductase from herpes simplex virus (types 1 and 2) infected and uninfected KB cells: properties of the partially purified enzymes.
Ponce de Leon M; Eisenberg RJ; Cohen GH
J Gen Virol; 1977 Jul; 36(1):163-73. PubMed ID: 18550
[TBL] [Abstract][Full Text] [Related]
19. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.
Karlsson A; Harmenberg J
Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the TK enzyme complex induced by HSV types 1 and 2 by means of isoelectric focusing and polyacrylamide gel electrophoresis.
Labenz J; Friedrich D; Falke D
Arch Virol; 1982; 71(3):235-49. PubMed ID: 6285860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]